BPC‑157 10mg is our gastric-derived pentadecapeptide format for groups interrogating peptide stability, angiogenic signalling, and cellular communication under controlled conditions. The 10mg presentation suits protocol design where tight dosing increments and multiple parallel assays are required from a single vial.

Researchers commonly use BPC‑157 to map pathway activation, assess behaviour across different cell types, or integrate it into stacked peptide models alongside agents such as TB500 or GHK‑Cu. The lyophilised powder reconstitutes cleanly, enabling reproducible concentration curves across experiments.

Supplied as a research-only compound, with batch testing and COA access available on request for data-driven projects.

Disclaimer: Not for human or animal use or consumption.